1 results match your criteria: "China Center for Reproductive Health Technical Instruction[Affiliation]"
[Clinical efficacy and safety of recombinant human-growth hormone in the treatment of idiopathic asthenospermia].
Zhonghua Nan Ke Xue
March 2007
International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University, China Center for Reproductive Health Technical Instruction, Shanghai 200030, China.
Objective: To evaluate the clinical efficacy and safety of recombinant human-growth hormone (rhGH) in the treatment of idiopathic asthenospermia.
Methods: Forty patients with idiopathic asthenospermia were recruited, randomly divided into an rhGH group and a control group and treated for 3 months. In addition to routine treatment, the rhGH group (n = 18) received rhGH, while the control group (n = 18) underwent the routine treatment only.